{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:28:27Z","timestamp":1786980507466,"version":"build-2736575974"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,2,21]],"date-time":"2017-02-21T00:00:00Z","timestamp":1487635200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s10072-017-2854-4","type":"journal-article","created":{"date-parts":[[2017,2,20]],"date-time":"2017-02-20T23:18:07Z","timestamp":1487632687000},"page":"827-831","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Treatment with telmisartan, a long-acting angiotensin II receptor blocker, prevents migraine attacks in Japanese non-responders to lomerizine"],"prefix":"10.1007","volume":"38","author":[{"given":"Ken","family":"Ikeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayori","family":"Hanashiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Kyuzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harumi","family":"Morioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junya","family":"Ebina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junpei","family":"Nagasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Yanagihashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehisa","family":"Hirayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Takazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Kano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyokazu","family":"Kawabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,21]]},"reference":[{"issue":"1","key":"2854_CR1","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1001\/jama.289.1.65","volume":"289","author":"E Tronvik","year":"2003","unstructured":"Tronvik E, Stovner LJ, Helde G, Sand T, Bovim G (2003) Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial. JAMA 289(1):65\u201369. doi:\n                        10.1001\/jama.289.1.65","journal-title":"JAMA"},{"issue":"7","key":"2854_CR2","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1177\/0333102413515348","volume":"34","author":"LJ Stovner","year":"2013","unstructured":"Stovner LJ, Linde M, Gravdahl GB, Tronvik E, Aamodt AH, Sand T, Hagen K (2013) A comparative study of candesartan versus propranolol for migraine prophylaxis: a randomised, triple-blind, placebo-controlled, double cross-over study. Cephalalgia 34(7):523\u2013532. doi:\n                        10.1177\/0333102413515348","journal-title":"Cephalalgia"},{"issue":"9","key":"2854_CR3","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1111\/j.1468-2982.2008.01825.x","volume":"29","author":"HC Diener","year":"2009","unstructured":"Diener HC, Gendolla A, Fruersenger A, Evers S, Straube A, Schumacher H, Davidai G (2009) Telmisartan in migraine prophylaxis: a randomized, placebo-controlled trial. Cephalalgia 29(9):921\u2013927. doi:\n                        10.1111\/j.1468-2982.2008.01825.x","journal-title":"Cephalalgia"},{"issue":"3","key":"2854_CR4","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/j.1526-4610.2006.00382.x","volume":"46","author":"JA Charles","year":"2006","unstructured":"Charles JA, Jotkowitz S, Byrd LH (2006) Prevention of migraine with olmesartan in patients with hypertension\/prehypertension. Headache 46(3):503\u2013507. doi:\n                        10.1111\/j.1526-4610.2006.00382.x","journal-title":"Headache"},{"issue":"8","key":"2854_CR5","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1111\/j.1526-4610.2006.00546_1.x","volume":"46","author":"Y Iwasaki","year":"2006","unstructured":"Iwasaki Y, Ikeda K (2006) Olmesartan, migraine, and blood Pressure. Headache 46(8):1309. doi:\n                        10.1111\/j.1526-4610.2006.00546_1.x","journal-title":"Headache"},{"issue":"8","key":"2854_CR6","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1007\/s10072-015-2217-y","volume":"36","author":"C Disco","year":"2015","unstructured":"Disco C, Maggioni F, Zanchin G (2015) Angiotensin II receptor blockers: a new possible treatment for chronic migraine? Neurol Sci 36(8):1483\u20131485. doi:\n                        10.1007\/s10072-015-2217-y","journal-title":"Neurol Sci"},{"issue":"1","key":"2854_CR7","first-page":"41","volume":"25","author":"H Kakuta","year":"2005","unstructured":"Kakuta H, Sudoh K, Sasamata M, Yamagishi S (2005) Telmisartan has the strongest binding affinity to angiotensin II type 1 receptor: comparison with other angiotensin II type 1 receptor blockers. Int J Clin Pharmacol Res 25(1):41\u201346","journal-title":"Int J Clin Pharmacol Res"},{"issue":"4","key":"2854_CR8","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00126097-200408000-00005","volume":"9","author":"Y Lacourci\u00e8re","year":"2004","unstructured":"Lacourci\u00e8re Y, Krzesinski J-M, White WB, Davidai G, Schumacher H (2004) Sustained antihypertensive activity of telmisartan compared with valsartan. Blood Press Monit 9(4):203\u2013210","journal-title":"Blood Press Monit"},{"issue":"4","key":"2854_CR9","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.amjhyper.2004.02.016","volume":"17","author":"WB White","year":"2004","unstructured":"White WB, Lacourciere Y, Davidai G (2004) Effects of the Angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure. Impact on the early morning period. Am J Hypertens 17(4):347\u2013353. doi:\n                        10.1016\/j.amjhyper.2004.02.016","journal-title":"Am J Hypertens"},{"issue":"1\u20132","key":"2854_CR10","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jns.2013.09.007","volume":"335","author":"M Ishii","year":"2013","unstructured":"Ishii M, Katoh H, Kurihara T, Kawamura M, Shimizu S (2013) Characteristics of inconsistent responders to prophylaxis therapy with lomerizine in patients with migraine: a retrospective study in Japan. J Neurol Sci 335(1\u20132):118\u2013123. doi:\n                        10.1016\/j.jns.2013.09.007","journal-title":"J Neurol Sci"},{"issue":"10","key":"2854_CR11","doi-asserted-by":"publisher","first-page":"683","DOI":"10.2169\/internalmedicine.46.6409","volume":"46","author":"N Imai","year":"2007","unstructured":"Imai N, Konishi T, Serizawa M, Okabe T (2007) Do the effects of long-term lomerizine administration differ with age? Inter Med 46(10):683\u2013684. doi:\n                        10.2169\/internalmedicine.46.6409","journal-title":"Inter Med"},{"issue":"9","key":"2854_CR12","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1177\/0333102413485658","volume":"33","author":"Headache Classification Committee of the International Headache Society","year":"2013","unstructured":"Headache Classification Committee of the International Headache Society (2013) The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33(9):629\u2013808. doi:\n                        10.1177\/0333102413485658","journal-title":"Cephalalgia"},{"issue":"8","key":"2854_CR13","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1023\/A:1026119331193","volume":"12","author":"M Kinoshita","year":"2003","unstructured":"Kinoshita M, Bayliss MS, Bjorner JB, Ware JE Jr, Garber WH, Batenhorst A, Cady R, Dahl\u00f6f CG, Doason A, Tepper S (2003) A six-item short-form survey for measuring headache impact: the HIT-6. Qual Life Res 12(8):963\u2013974","journal-title":"Qual Life Res"},{"issue":"1","key":"2854_CR14","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1152\/japplphysiol.01278.2007","volume":"106","author":"R Zhang","year":"2009","unstructured":"Zhang R, Bai YG, Lin LJ, Bao JX, Zhang YY, Tang H, Cheng JH, Jia GL, Ren XL, Ma J (2009) Blockade of AT1 receptor partially restores vasoreactivity, NOS expression, and superoxide levels in cerebral and carotid arteries of hindlimb unweighting rats. J Appl Physiol 106(1):251\u2013258. doi:\n                        10.1152\/japplphysiol.01278.2007","journal-title":"J Appl Physiol"},{"issue":"4","key":"2854_CR15","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/j.neuroscience.2008.11.044","volume":"158","author":"J Marques-Lopes","year":"2009","unstructured":"Marques-Lopes J, Pinto M, Pinho D, Morato M, Patinha D, Albino-Teixeira A, Tavares I (2009) Microinjection of angiotensin II in the caudal ventrolateral medulla induces hyperalgesia. Neuroscience 158(4):1301\u20131310. doi:\n                        10.1016\/j.neuroscience.2008.11.044","journal-title":"Neuroscience"},{"issue":"1","key":"2854_CR16","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1291\/hypres.31.161","volume":"31","author":"M Iwai","year":"2008","unstructured":"Iwai M, Inaba S, Tomono Y, Kanno H, Iwanami J, Mogi M, Horinouchi M (2008) Attenuation of focal brain ischemia by telmisartan, an angiotensin II type 1 receptor blocker, in atherosclerotic apolipoprotein E-deficient mice. Hypertens Res 31(1):161\u2013168. doi:\n                        10.1291\/hypres.31.161","journal-title":"Hypertens Res"},{"issue":"1","key":"2854_CR17","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/head.12008","volume":"53","author":"B Horasanli","year":"2013","unstructured":"Horasanli B, Ata\u00e7 FB, \u00c7\u00f6ven I, Karakurum Goksel B, Benli S (2013) Angiotensin I-converting enzyme gene (I\/D) polymorphism in patients with migraine. Headache 53(1):161\u2013164. doi:\n                        10.1111\/head.12008","journal-title":"Headache"},{"issue":"2","key":"2854_CR18","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.neulet.2004.10.041","volume":"374","author":"H Kowa","year":"2005","unstructured":"Kowa H, Fusayasu E, Ijiri T, Ishizaki K, Yasui K, Nakaso K, Kusumi M, Takeshita T, Nakashima K (2005) Association of the insertion\/deletion polymorphism of the angiotensin I-converting enzyme gene in patients of migraine with aura. Neurosci Lett 374(2):129\u2013131","journal-title":"Neurosci Lett"},{"issue":"3","key":"2854_CR19","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000008151","volume":"43","author":"S Paterna","year":"2000","unstructured":"Paterna S, Di Pasquale P, D\u2019Angelo A, Seidita G, Tuttolomondo A, Cardinale A, Maniscalchi T, Follone G, Giubilato A, Tarantello M, Licata G (2000) Angiotensin-converting enzyme gene deletion polymorphism determines an increase in frequency of migraine attacks in patients suffering from migraine without aura. Eur Neurol 43(3):133\u2013136","journal-title":"Eur Neurol"},{"issue":"1","key":"2854_CR20","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.1097\/01.hjh.0000220419.86149.11","volume":"24","author":"E Tronvik","year":"2006","unstructured":"Tronvik E, Stovner LJ, Schrader H, Bovim G (2006) Involvement of the renin-angiotensin system in migraine. J Hypertens Suppl 24(1):S139\u2013S143","journal-title":"J Hypertens Suppl"},{"issue":"4","key":"2854_CR21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11940-016-0397-2","volume":"18","author":"RB Halker","year":"2016","unstructured":"Halker RB, Starling AJ, Vargas BB, Schwedt TJ (2016) ACE and ARB agents in the prophylactic therapy of migraine-how effective are they? Curr Treat Options Neurol 18(4):15. doi:\n                        10.1007\/s11940-016-0397-2","journal-title":"Curr Treat Options Neurol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-017-2854-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-017-2854-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-017-2854-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T07:09:19Z","timestamp":1495523359000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-017-2854-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,21]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["2854"],"URL":"https:\/\/doi.org\/10.1007\/s10072-017-2854-4","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,21]]}}}